Analysis of Gut Microbiota in Patients with Coronary Artery Disease and Hypertension. (27th December 2021)

• Record Type: Journal Article
• Authors: Wan, Chuanqi; Zhu, Chen; Jin, Gulei; Zhu, Min; Hua, Junyi; He, Yuzhou
• Other Names: Wan Jin-Yi Academic Editor.
• Is Part Of: Evidence-based complementary and alternative medicine. Volume 2021(2021)
• Publication Date: 2021-12-27
• Subjects: Alternative medicine -- Periodicals; 615.505
• DOI: 10.1155/2021/7195082
• Languages: English
• ISSNs: 1741-427X

Abstract

Abstract : Cardiovascular and cerebrovascular diseases are characterized by high rates of morbidity and mortality. Microbiota is closely associated with cardiovascular disease. We aimed to comprehensively analyze the microbiotas of 300 healthy controls, 300 patients with high blood pressure (HBP), and 300 patients with coronary heart disease (CHD). The results indicated no significant difference in microbiota diversity among the three groups (P > 0.05 ). However, differences in microbiota richness among the three groups were significant (P < 0.05 ). Bacteroidetes and Bacteroidia were the dominant bacteria in the CHD group, Enterobacteriales and Escherichia-shigella in the HBP group, and Acidaminococcaceae and Phascolarctobacterium in the healthy control group. The prediction results of the random forest model indicated that the population with CHD displayed prominent features with high sensitivity, indicating that microbiota detection might become a novel clinical indicator to predict and monitor the risk of cardiovascular events. The prediction of microbiota function suggested differences in oxygen supply and chronic inflammation between populations with HBP/CHD and healthy populations. Although there is no difference in gut microbiota diversity among the three groups, each group has its dominant microbiota in terms of richness.